Marek Trněný
MD, PhD from Charles University Hospital, Prague, Czech Republic. Contributed to clinical trials on BTK inhibitors in mantle cell lymphoma.
Best podcasts with Marek Trněný
Ranked by the Snipd community
Oct 30, 2024 • 10min
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
Join experts Krish Patel, MD, specializing in mantle cell lymphoma treatment, Marek Trněný, MD, PhD, a key contributor to BTK inhibitor trials, and Michael Wang, MD, who offers insights on therapeutic sequencing. They delve into groundbreaking trials like ECHO and SHINE, discussing the role of BTK inhibitors and their effectiveness for older patients. Notably, they address optimal sequencing methods to prevent cross-resistance and strategies for managing cardiac toxicities. Their collaboration underscores a comprehensive approach to enhancing patient care.
Nov 3, 2023 • 15min
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
In this podcast, experts Stephen Ansell and Marek Trněný discuss the evolving treatment landscape in mantle cell lymphoma. They explore the impact of stem cell transplants, the emergence of novel therapies, and the importance of maintenance therapy. Different treatment approaches, including CAR T cell therapy, are also discussed along with the potential for cure and long-term survival rates.
